Cartherics Pty ltd

Cartherics is developing its novel “off-the-shelf” (allogeneic) immune therapy products for the treatment of cancer based on immune killer cells. The company is developing large-scale manufacture of these CAR-iNK cells for application in human trials. Our technology seeks to harness the power of Natural Killer (NK) cells, T cells & macrophages within the immune system, to fight against solid tumours. We’re researching a portfolio of allogeneic therapies that increase safety, efficacy and accessibility compared to existing CAR-T therapies. We are confident that our brilliant team will take us to recognition as the premier immune therapy start-up in Australia, and worthy of comparison with the best worldwide.